{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T21:18:34Z","timestamp":1795123114128,"version":"4.10.3"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000923","name":"Department of Education and Training | Australian Research Council","doi-asserted-by":"publisher","award":["CE200100012"],"award-info":[{"award-number":["CE200100012"]}],"id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1174941"],"award-info":[{"award-number":["1174941"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1153493"],"award-info":[{"award-number":["1153493"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2011467"],"award-info":[{"award-number":["2011467"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Targeting the protein quality control system in\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    represents a promising and underexplored opportunity for antibiotic development. The ClpC1:ClpP1P2 protease is an essential component of the system that mediates both regulatory and stress-related protein degradation. Several non-ribosomal peptide natural products, including ecumicin, ilamycins (rufomycins) and cyclomarins, have been discovered that bind to the ClpC1 chaperone of the complex and exhibit potent antimycobacterial activity, leading to significant interest in the ClpC1:ClpP1P2 system as a bona fide target for the new tuberculosis drugs. In this study, we combine quantitative proteomics, bioinformatics, transcriptomics, CRISPRi knockdown, and targeted biochemical and biophysical assays to dissect the mechanisms of ecumicin, ilamycin and cyclomarin in clinically relevant\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    . Strikingly, despite exhibiting similar binding modes to ClpC1, each compound induces distinct effects on protein degradation. Notably, ilamycin and ecumicin do not trigger the ClpC2 rescue mechanism that mitigates cyclomarin-induced mycobacterial toxicity. In addition, we identify a novel interaction between ecumicin and stress-response chaperone Hsp20. The differential disruption of ClpC1 substrates, stress-response chaperones, and distinct reshaping of the\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    proteome by the three natural products, unveils new opportunities for the development of protein quality control-targeted antimycobacterials.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-68423-2","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:49:51Z","timestamp":1769701791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["ClpC1-targeting peptide natural products differentially dysregulate the proteome of Mycobacterium tuberculosis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2284-9163","authenticated-orcid":false,"given":"Isabel K.","family":"Barter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max J.","family":"Bedding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3632-056X","authenticated-orcid":false,"given":"Julia","family":"Leodolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W. C.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige M. E.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9876-003X","authenticated-orcid":false,"given":"Maxwell T.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7747-7745","authenticated-orcid":false,"given":"Matthew B.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Jowsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trixie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9846-4505","authenticated-orcid":false,"given":"Sabryna","family":"Junker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Fl\u00f3rido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hesselson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8349-1500","authenticated-orcid":false,"given":"Gregory M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-6924","authenticated-orcid":false,"given":"Tim","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6721-9646","authenticated-orcid":false,"given":"Warwick J.","family":"Britton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-2267","authenticated-orcid":false,"given":"Mark","family":"Larance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3618-9226","authenticated-orcid":false,"given":"Richard J.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"68423_CR1","unstructured":"World Health Organisation. Global Tuberculosis Report 2024. can be found at https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024 (2024)."},{"key":"68423_CR2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(24)00154-3","volume":"24","author":"R Dinkele","year":"2024","unstructured":"Dinkele, R., Khan, P. Y. & Warner, D. F. Mycobacterium tuberculosis transmission: the importance of precision. Lancet Infect. Dis. 24, 679\u2013681 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"68423_CR3","doi-asserted-by":"crossref","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","volume":"27","author":"S Ravimohan","year":"2018","unstructured":"Ravimohan, S., Kornfeld, H., Weissman, D. & Bisson, G. P. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur. Respir. J. 27, 170077 (2018).","journal-title":"Eur. Respir. J."},{"key":"68423_CR4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41573-024-00897-5","volume":"23","author":"V Dartois","year":"2024","unstructured":"Dartois, V. & Dick, T. Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease. Nat. Rev. Drug Discov. 23, 381\u2013403 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68423_CR5","doi-asserted-by":"crossref","first-page":"32244","DOI":"10.1021\/acsomega.3c02563","volume":"8","author":"RSK Sachan","year":"2023","unstructured":"Sachan, R. S. K. et al. Overcoming Mycobacterium tuberculosis drug resistance: novel medications and repositioning strategies. ACS Omega 8, 32244\u201332257 (2023).","journal-title":"ACS Omega"},{"key":"68423_CR6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"JMA Blair","year":"2015","unstructured":"Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O. & Piddock, L. J. V. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 13, 42\u201351 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"68423_CR7","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1073\/pnas.1620646114","volume":"114","author":"M Santra","year":"2017","unstructured":"Santra, M., Farrell, D. W. & Dill, K. A. Bacterial proteostasis balances energy and chaperone utilization efficiently. Proc. Natl. Acad. Sci. USA 114, 2654\u20132661 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68423_CR8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cell.2006.04.014","volume":"125","author":"B Bukau","year":"2006","unstructured":"Bukau, B., Weissman, J. & Horwich, A. L. Molecular chaperones and protein quality control. Cell 125, 443\u2013451 (2006).","journal-title":"Cell"},{"key":"68423_CR9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1021\/acsinfecdis.7b00231","volume":"4","author":"TJ Lupoli","year":"2018","unstructured":"Lupoli, T. J., Vaubourgeix, J., Burns-Huang, K. & Gold, B. Targeting the proteostasis network for mycobacterial drug discovery. ACS Infect. Dis. 4, 478\u2013498 (2018).","journal-title":"ACS Infect. Dis."},{"key":"68423_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/clinids\/5.Supplement_3.S407","volume":"5","author":"W Wehrli","year":"1983","unstructured":"Wehrli, W. Rifampin: mechanisms of action and resistance. Rev. Infect. Dis. 5, 407\u2013411 (1983).","journal-title":"Rev. Infect. Dis."},{"key":"68423_CR11","doi-asserted-by":"crossref","first-page":"19192","DOI":"10.1039\/C9CP03631H","volume":"21","author":"JF Vianna","year":"2019","unstructured":"Vianna, J. F., S Bezerra, K., I. N. Oliveira, J., Albuquerque, E. L. & Fulco, U. L. Binding energies of the drugs capreomycin and streptomycin in complex with tuberculosis bacterial ribosome subunits. Phys. Chem. Chem. Phys. 21, 19192\u201319200 (2019).","journal-title":"Phys. Chem. Chem. Phys."},{"key":"68423_CR12","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/DDDT.S164515","volume":"12","author":"SM Hashemian","year":"2018","unstructured":"Hashemian, S. M., Farhadi, T. & Ganjparvar, M. Linezolid: a review of its properties, function, and use in critical care. Drug Des. Dev. Ther. 12, 1759\u20131767 (2018).","journal-title":"Drug Des. Dev. Ther."},{"key":"68423_CR13","doi-asserted-by":"crossref","first-page":"02133","DOI":"10.1128\/mBio.02133-16","volume":"8","author":"MA Dejesus","year":"2017","unstructured":"Dejesus, M. A. et al. Comprehensive essentiality analysis of the Mycobacterium tuberculosis genome via saturating transposon mutagenesis. mBio 8, 02133\u201302116 (2017).","journal-title":"mBio"},{"key":"68423_CR14","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1074\/jbc.RA120.013456","volume":"295","author":"A Lunge","year":"2020","unstructured":"Lunge, A., Gupta, R., Choudhary, E. & Agarwal, N. The unfoldase ClpC1 of Mycobacterium tuberculosis regulates the expression of a distinct subset of proteins having intrinsically disordered termini. J. Biol. Chem. 295, 9455\u20139473 (2020).","journal-title":"J. Biol. Chem."},{"key":"68423_CR15","doi-asserted-by":"crossref","first-page":"1003994","DOI":"10.1371\/journal.ppat.1003994","volume":"10","author":"RM Raju","year":"2014","unstructured":"Raju, R. M. et al. Post-translational regulation via clp protease is critical for survival of Mycobacterium tuberculosis. PLoS Pathog. 10, 1003994 (2014).","journal-title":"PLoS Pathog."},{"key":"68423_CR16","doi-asserted-by":"crossref","first-page":"4587","DOI":"10.1073\/pnas.1417120111","volume":"111","author":"KR Schmitz","year":"2014","unstructured":"Schmitz, K. R., Carney, D. W., Sello, J. K. & Sauer, R. T. Crystal structure of Mycobacterium tuberculosis ClpP1P2 suggests a model for peptidase activation by AAA+ partner binding and substrate delivery. Proc. Natl. Acad. Sci. USA 111, 4587\u20134595 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68423_CR17","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.1074\/jbc.M115.700344","volume":"291","author":"M Li","year":"2016","unstructured":"Li, M. et al. Structure and functional properties of the active form of the proteolytic complex, ClpP1P2, from Mycobacterium tuberculosis*. J. Biol. Chem. 291, 7465\u20137476 (2016).","journal-title":"J. Biol. Chem."},{"key":"68423_CR18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/emboj.2012.5","volume":"31","author":"T Akopian","year":"2012","unstructured":"Akopian, T. et al. The active ClpP protease from M. tuberculosis is a complex composed of a heptameric ClpP1 and a ClpP2 ring. EMBO J. 31, 1529\u20131541 (2012).","journal-title":"EMBO J."},{"key":"68423_CR19","doi-asserted-by":"crossref","first-page":"102553","DOI":"10.1016\/j.jbc.2022.102553","volume":"298","author":"K Weinh\u00e4upl","year":"2022","unstructured":"Weinh\u00e4upl, K. et al. Structure of the drug target ClpC1 unfoldase in action provides insights on antibiotic mechanism of action. J. Biol. Chem. 298, 102553 (2022).","journal-title":"J. Biol. Chem."},{"key":"68423_CR20","doi-asserted-by":"crossref","unstructured":"Weinh\u00e4upl, K. et al. Activation mechanism and structural assembly of the Mycobacterium tuberculosis ClpP1P2 protease and its associated ATPases. Preprint at https:\/\/www.biorxiv.org\/content\/10.1101\/2025.02.28.640722v1 (2025).","DOI":"10.1101\/2025.02.28.640722"},{"key":"68423_CR21","volume":"15","author":"HI Won","year":"2024","unstructured":"Won, H. I. et al. Targeted protein degradation in mycobacteria uncovers antibacterial effects and potentiates antibiotic efficacy. Nat. Commun. 15, 4065 (2024).","journal-title":"Nat. Commun."},{"key":"68423_CR22","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1021\/ol5026603","volume":"16","author":"W Gao","year":"2014","unstructured":"Gao, W. et al. Discovery and characterization of the tuberculosis drug lead ecumicin. Org. Lett. 16, 6044\u20136047 (2014).","journal-title":"Org. Lett."},{"key":"68423_CR23","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1021\/acs.orglett.8b02643","volume":"20","author":"Y Cheng","year":"2018","unstructured":"Cheng, Y., Tang, S., Guo, Y. & Ye, T. Total synthesis of anti-tuberculosis natural products ilamycins E1 and F. Org. Lett. 20, 6166\u20136169 (2018).","journal-title":"Org. Lett."},{"key":"68423_CR24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/acs.orglett.5b03292","volume":"18","author":"P Barbie","year":"2016","unstructured":"Barbie, P. & Kazmaier, U. Total synthesis of cyclomarin A, a marine cycloheptapeptide with anti-tuberculosis and anti-malaria activity. Org. Lett. 18, 204\u2013207 (2016).","journal-title":"Org. Lett."},{"key":"68423_CR25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.chembiol.2014.01.014","volume":"21","author":"E Gavrish","year":"2014","unstructured":"Gavrish, E. et al. Lassomycin, a ribosomally synthesized cyclic peptide, kills mycobacterium tuberculosis by targeting the ATP-dependent protease ClpC1P1P2. Chem. Biol. 21, 509\u2013518 (2014).","journal-title":"Chem. Biol."},{"key":"68423_CR26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1021\/acs.orglett.7b03967","volume":"20","author":"PME Hawkins","year":"2018","unstructured":"Hawkins, P. M. E., Giltrap, A. M., Nagalingam, G., Britton, W. J. & Payne, R. J. Total synthesis of ecumicin. Org. Lett. 20, 1019\u20131022 (2018).","journal-title":"Org. Lett."},{"key":"68423_CR27","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1021\/ol049065n","volume":"6","author":"S Wen","year":"2004","unstructured":"Wen, S. & Yao, Z. Total synthesis of cyclomarin C. Org. Lett. 6, 2721\u20132724 (2004).","journal-title":"Org. Lett."},{"key":"68423_CR28","doi-asserted-by":"crossref","first-page":"30883","DOI":"10.1074\/jbc.M113.493767","volume":"288","author":"D Vasudevan","year":"2013","unstructured":"Vasudevan, D., Rao, S. P. & Noble, C. G. Structural basis of mycobacterial inhibition by cyclomarin A. J. Biol. Chem. 288, 30883\u201330891 (2013).","journal-title":"J. Biol. Chem."},{"key":"68423_CR29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1021\/acsinfecdis.8b00276","volume":"5","author":"NM Wolf","year":"2019","unstructured":"Wolf, N. M. et al. High-resolution structure of ClpC1-rufomycin and ligand binding studies provide a framework to design and optimize anti-tuberculosis leads. ACS Infect. Dis. 5, 829\u2013840 (2019).","journal-title":"ACS Infect. Dis."},{"key":"68423_CR30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1107\/S2059798320004027","volume":"76","author":"NM Wolf","year":"2020","unstructured":"Wolf, N. M. et al. Structure of the N-terminal domain of ClpC1 in complex with the antituberculosis natural product ecumicin reveals unique binding interactions. Acta Crystallogr., Sect. D: Struct. Biol. 76, 458\u2013471 (2020).","journal-title":"Acta Crystallogr., Sect. D: Struct. Biol."},{"key":"68423_CR31","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1038\/s44318-025-00575-1","volume":"44","author":"T Jenne","year":"2025","unstructured":"Jenne, T. et al. Allosteric control of the bacterial ClpC\/ClpP protease and its hijacking by antibacterial peptides. EMBO J. 44, 6273\u20136296 (2025).","journal-title":"EMBO J."},{"key":"68423_CR32","doi-asserted-by":"crossref","first-page":"126771","DOI":"10.1016\/j.ijbiomac.2023.126771","volume":"253","author":"MK Jagdev","year":"2023","unstructured":"Jagdev, M. K. et al. Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin. Int. J. Biol. Macromol. 253, 126771 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"68423_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46218-7","volume":"15","author":"L Junk","year":"2024","unstructured":"Junk, L. et al. Homo-BacPROTAC-induced degradation of ClpC1 as a strategy against drug-resistant mycobacteria. Nat. Commun. 15, 2005 (2024).","journal-title":"Nat. Commun."},{"key":"68423_CR34","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.cell.2023.04.009","volume":"186","author":"DM Hoi","year":"2023","unstructured":"Hoi, D. M. et al. Clp-targeting BacPROTACs impair mycobacterial proteostasis and survival. Cell 186, 2176\u20132192 (2023).","journal-title":"Cell"},{"key":"68423_CR35","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.cell.2022.05.009","volume":"185","author":"FE Morreale","year":"2022","unstructured":"Morreale, F. E. et al. BacPROTACs mediate targeted protein degradation in bacteria. Cell 185, 2338\u20132353 (2022).","journal-title":"Cell"},{"key":"68423_CR36","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1021\/acs.jmedchem.1c02122","volume":"65","author":"PME Hawkins","year":"2022","unstructured":"Hawkins, P. M. E. et al. Potent bactericidal antimycobacterials targeting the chaperone ClpC1 based on the depsipeptide natural products ecumicin and ohmyungsamycin A. J. Med. Chem. 65, 4893\u20134908 (2022).","journal-title":"J. Med. Chem."},{"key":"68423_CR37","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1021\/acs.jnatprod.1c00198","volume":"84","author":"B Zhou","year":"2021","unstructured":"Zhou, B. et al. Rufomycins or ilamycins: naming clarifications and definitive structural assignments. J. Nat. Prod. 84, 2644\u20132663 (2021).","journal-title":"J. Nat. Prod."},{"key":"68423_CR38","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1021\/acs.orglett.4c04163","volume":"26","author":"MJ Bedding","year":"2024","unstructured":"Bedding, M. J. et al. Modular total synthesis and antimycobacterial activity of rufomycins. Org. Lett. 26, 10993\u201310998 (2024).","journal-title":"Org. Lett."},{"key":"68423_CR39","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1039\/C6OB00801A","volume":"14","author":"P Barbie","year":"2016","unstructured":"Barbie, P. & Kazmaier, U. Total synthesis of desoxycyclomarin C and the cyclomarazines A and B. Org. Biomol. Chem. 14, 6055\u20136064 (2016).","journal-title":"Org. Biomol. Chem."},{"key":"68423_CR40","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1002\/anie.201101740","volume":"50","author":"EK Schmitt","year":"2011","unstructured":"Schmitt, E. K. et al. The natural product cyclomarin kills Mycobacterium tuberculosis by targeting the ClpC1 subunit of the caseinolytic protease. Angew. Chem. Int. Ed. 50, 5889\u20135891 (2011).","journal-title":"Angew. Chem. Int. Ed."},{"key":"68423_CR41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.tube.2010.09.006","volume":"91","author":"A Kapopoulou","year":"2011","unstructured":"Kapopoulou, A., Lew, J. M. & Cole, S. T. The MycoBrowser portal: a comprehensive and manually annotated resource for mycobacterial genomes. Tuberculosis 91, 8\u201313 (2011).","journal-title":"Tuberculosis"},{"key":"68423_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/febs.15335","volume":"288","author":"M Ziemski","year":"2021","unstructured":"Ziemski, M., Leodolter, J., Taylor, G., Kerschenmeyer, A. & Weber-Ban, E. Genome-wide interaction screen for Mycobacterium tuberculosis ClpCP protease reveals toxin-antitoxin systems as a major substrate class. FEBS J. 288, 111\u2013126 (2021).","journal-title":"FEBS J."},{"key":"68423_CR43","doi-asserted-by":"crossref","first-page":"00253","DOI":"10.1128\/mBio.00253-15","volume":"6","author":"W Moreira","year":"2015","unstructured":"Moreira, W. et al. Target mechanism-based whole-cell screening identifies bortezomib as an inhibitor of caseinolytic protease in Mycobacteria. mBio 6, 00253\u201300215 (2015).","journal-title":"mBio"},{"key":"68423_CR44","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fmicb.2017.00746","volume":"8","author":"W Moreira","year":"2017","unstructured":"Moreira, W., Santhanakrishnan, S., Dymock, B. W. & Dick, T. Bortezomib warhead-switch confers dual activity against mycobacterial caseinolytic protease and proteasome and selectivity against human proteasome. Front. Microbiol. 8, 746 (2017).","journal-title":"Front. Microbiol."},{"key":"68423_CR45","volume":"16","author":"B Zhou","year":"2025","unstructured":"Zhou, B. et al. Structural insights into bortezomib-induced activation of the caseinolytic chaperone-protease system in Mycobacterium tuberculosis. Nat. Commun. 16, 3466 (2025).","journal-title":"Nat. Commun."},{"key":"68423_CR46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1096\/fj.05-5495com","volume":"20","author":"Q Ding","year":"2006","unstructured":"Ding, Q., Dimayuga, E., Markesbery, W. R. & Keller, J. N. Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J. 20, 1055\u20131063 (2006).","journal-title":"FASEB J."},{"key":"68423_CR47","doi-asserted-by":"crossref","first-page":"e00338","DOI":"10.1128\/mSphere.00338-16","volume":"2","author":"Y Yamada","year":"2017","unstructured":"Yamada, Y. & Dick, T. Mycobacterial caseinolytic protease gene regulator ClgR is a substrate of caseinolytic protease. mSphere 2, e00338\u201316 (2017).","journal-title":"mSphere"},{"key":"68423_CR48","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-15516-1","volume":"11","author":"P Gopal","year":"2020","unstructured":"Gopal, P. et al. Pyrazinamide triggers degradation of its target aspartate decarboxylase. Nat. Commun. 11, 1661 (2020).","journal-title":"Nat. Commun."},{"key":"68423_CR49","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/jasms.4c00080","volume":"35","author":"LW Henderson","year":"2024","unstructured":"Henderson, L. W. et al. Bortezomib inhibits open configurations of the 20S proteasome. J. Am. Soc. Mass Spectrom. 35, 1063\u20131068 (2024).","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"68423_CR50","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1038\/sj.emboj.7601405","volume":"25","author":"MJ Pearce","year":"2006","unstructured":"Pearce, M. J. et al. Identification of substrates of the Mycobacterium tuberculosis proteasome. EMBO J. 25, 5423\u20135432 (2006).","journal-title":"EMBO J."},{"key":"68423_CR51","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1073\/pnas.1423319112","volume":"112","author":"JB Jastrab","year":"2015","unstructured":"Jastrab, J. B. et al. An adenosine triphosphate-independent proteasome activator contributes to the virulence of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 112, 1763\u20131772 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"68423_CR52","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-27787-3","volume":"13","author":"M Kavalchuk","year":"2022","unstructured":"Kavalchuk, M., Jomaa, A., M\u00fcller, A. U. & Weber-Ban, E. Structural basis of prokaryotic ubiquitin-like protein engagement and translocation by the mycobacterial Mpa-proteasome complex. Nat. Commun. 13, 276 (2022).","journal-title":"Nat. Commun."},{"key":"68423_CR53","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/mmi.12694","volume":"93","author":"KR Schmitz","year":"2014","unstructured":"Schmitz, K. R. & Sauer, R. T. Substrate delivery by the AAA+ ClpX and ClpC1 unfoldases activates the mycobacterial ClpP1P2 peptidase. Mol. Microbiol. 93, 617\u2013628 (2014).","journal-title":"Mol. Microbiol."},{"key":"68423_CR54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12122-y","volume":"7","author":"SG Stahlhut","year":"2017","unstructured":"Stahlhut, S. G. et al. The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureus. Sci. Rep. 7, 11739 (2017).","journal-title":"Sci. Rep."},{"key":"68423_CR55","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1128\/JB.182.11.3259-3265.2000","volume":"182","author":"E Kruger","year":"2000","unstructured":"Kruger, E., Witt, E., Ohlmeier, S., Hanschke, R. & Hecker, M. The clp proteases of Bacillus subtilis are directly involved in degradation of misfolded proteins. J. Bacteriol. 182, 3259\u20133265 (2000).","journal-title":"J. Bacteriol."},{"key":"68423_CR56","doi-asserted-by":"crossref","first-page":"14050","DOI":"10.3390\/ijms232214050","volume":"23","author":"R Trivedi","year":"2022","unstructured":"Trivedi, R. & Nagarajaram, H. A. Intrinsically disordered proteins: an overview. Int. J. Mol. Sci. 23, 14050 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"68423_CR57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/nar\/gkac1065","volume":"51","author":"D Piovesan","year":"2023","unstructured":"Piovesan, D. et al. MobiDB: 10 years of intrinsically disordered proteins. Nucleic Acids Res. 51, 438\u2013444 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68423_CR58","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1002\/pro.4466","volume":"31","author":"D Piovesan","year":"2022","unstructured":"Piovesan, D., Monzon, A. M. & Tosatto, S. C. E. Intrinsic protein disorder and conditional folding in AlphaFoldDB. Protein Sci. 31, 4466 (2022).","journal-title":"Protein Sci."},{"key":"68423_CR59","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s42003-023-04658-9","volume":"6","author":"G Taylor","year":"2023","unstructured":"Taylor, G., Cui, H., Leodolter, J., Giese, C. & Weber-Ban, E. ClpC2 protects mycobacteria against a natural antibiotic targeting ClpC1-dependent protein degradation. Commun. Biol. 6, 301 (2023).","journal-title":"Commun. Biol."},{"key":"68423_CR60","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1021\/acsinfecdis.5c00689","volume":"11","author":"PME Hawkins","year":"2025","unstructured":"Hawkins, P. M. E. et al. ClpC1 modulating ohmyungsamycin A and ecumicin natural product analogues are potent antimycobacterials. ACS Infect. Dis. 11, 3298\u20133309 (2025).","journal-title":"ACS Infect. Dis."},{"key":"68423_CR61","doi-asserted-by":"crossref","first-page":"33419","DOI":"10.1074\/jbc.M504263200","volume":"280","author":"CK Kennaway","year":"2005","unstructured":"Kennaway, C. K. et al. Dodecameric structure of the small heat shock protein Acr1 from Mycobacterium tuberculosis. J. Biol. Chem. 280, 33419\u201333425 (2005).","journal-title":"J. Biol. Chem."},{"key":"68423_CR62","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1371\/journal.pone.0011622","volume":"5","author":"AM Sherrid","year":"2010","unstructured":"Sherrid, A. M., Rustad, T. R., Cangelosi, G. A. & Sherman, D. R. Characterization of a Clp protease gene regulator and the reaeration response in Mycobacterium tuberculosis. PLoS ONE 5, 11622 (2010).","journal-title":"PLoS ONE"},{"key":"68423_CR63","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1099\/mic.0.042275-0","volume":"156","author":"M Estorninho","year":"2010","unstructured":"Estorninho, M. et al. ClgR regulation of chaperone and protease systems is essential for Mycobacterium tuberculosis parasitism of the macrophage. Microbiology 156, 3445\u20133455 (2010).","journal-title":"Microbiology"},{"key":"68423_CR64","doi-asserted-by":"crossref","first-page":"1002511","DOI":"10.1371\/journal.ppat.1002511","volume":"8","author":"RM Raju","year":"2012","unstructured":"Raju, R. M. et al. Mycobacterium tuberculosis ClpP1 and ClpP2 function together in protein degradation and are required for viability in vitro and during infection. PLoS Pathog. 8, 1002511 (2012).","journal-title":"PLoS Pathog."},{"key":"68423_CR65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/femsre\/fuz026","volume":"44","author":"FD Schramm","year":"2020","unstructured":"Schramm, F. D., Schroeder, K. & Jonas, K. Protein aggregation in bacteria. FEMS Microbiol. Rev. 44, 54\u201372 (2020).","journal-title":"FEMS Microbiol. Rev."},{"key":"68423_CR66","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02703105","volume":"21","author":"R Chowdhury","year":"1996","unstructured":"Chowdhury, R., Sahu, G. K. & Das, J. Stress response in pathogenic bacteria. J. Biosci. 21, 149\u2013160 (1996).","journal-title":"J. Biosci."},{"key":"68423_CR67","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1101\/gad.11.7.815","volume":"11","author":"S Gottesman","year":"1997","unstructured":"Gottesman, S., Wickner, S. & Maurizi, M. R. Protein quality control: triage by chaperones and proteases. Genes Dev. 11, 815\u2013823 (1997).","journal-title":"Genes Dev."},{"key":"68423_CR68","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.chom.2013.04.008","volume":"13","author":"OT Schubert","year":"2013","unstructured":"Schubert, O. T. et al. The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosis. Cell Host Microbe 13, 602\u2013612 (2013).","journal-title":"Cell Host Microbe"},{"key":"68423_CR69","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1128\/AAC.04054-14","volume":"59","author":"W Gao","year":"2015","unstructured":"Gao, W. et al. The cyclic peptide ecumicin targeting ClpC1 is active against Mycobacterium tuberculosis in vivo. Antimicrob. Agents Chemother. 59, 880\u2013889 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"68423_CR70","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.chembiol.2019.05.008","volume":"26","author":"M Maurer","year":"2019","unstructured":"Maurer, M. et al. Toxic activation of an AAA+ protease by the antibacterial drug cyclomarin A. Cell Chem. Biol. 26, 1169\u20131179.e1164 (2019).","journal-title":"Cell Chem. Biol."},{"key":"68423_CR71","doi-asserted-by":"crossref","first-page":"102202","DOI":"10.1016\/j.jbc.2022.102202","volume":"298","author":"G Taylor","year":"2022","unstructured":"Taylor, G. et al. Antibacterial peptide cyclomarinA creates toxicity by deregulating the Mycobacterium tuberculosis ClpC1-ClpP1P2 protease. J. Biol. Chem. 298, 102202 (2022).","journal-title":"J. Biol. Chem."},{"key":"68423_CR72","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s12192-020-01094-0","volume":"25","author":"I Obuchowski","year":"2020","unstructured":"Obuchowski, I. & Liberek, K. Small but mighty: a functional look at bacterial sHSPs. Cell Stress Chaperones 25, 593\u2013600 (2020).","journal-title":"Cell Stress Chaperones"},{"key":"68423_CR73","doi-asserted-by":"crossref","first-page":"16274","DOI":"10.1038\/nmicrobiol.2016.274","volume":"2","author":"JM Rock","year":"2017","unstructured":"Rock, J. M. et al. Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform. Nat. Microbiol. 2, 16274 (2017).","journal-title":"Nat. Microbiol."},{"key":"68423_CR74","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/jac\/dkab437","volume":"77","author":"C Cheung","year":"2022","unstructured":"Cheung, C., McNeil, M. B. & Cook, G. M. Utilization of CRISPR interference to investigate the contribution of genes to pathogenesis in a macrophage model of Mycobacterium tuberculosis infection. J. Antimicrob. Chemother. 77, 615\u2013619 (2022).","journal-title":"J. Antimicrob. Chemother."},{"key":"68423_CR75","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"68423_CR76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125345","volume":"10","author":"J Leodolter","year":"2015","unstructured":"Leodolter, J., Warweg, J. & Weber-Ban, E. The Mycobacterium tuberculosis ClpP1P2 protease interacts asymmetrically with its ATPase partners ClpX and ClpC1. PLoS ONE 10, e0131132 (2015).","journal-title":"PLoS ONE"},{"key":"68423_CR77","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"68423_CR78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"68423_CR79","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.2","volume":"4","author":"C Soneson","year":"2016","unstructured":"Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research 4, 1521 (2016).","journal-title":"F1000Research"},{"key":"68423_CR80","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"68423_CR81","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/bioinformatics\/bty895","volume":"35","author":"A Zhu","year":"2019","unstructured":"Zhu, A., Ibrahim, J. G. & Love, M. I. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics 35, 2084\u20132092 (2019).","journal-title":"Bioinformatics"},{"key":"68423_CR82","doi-asserted-by":"crossref","first-page":"108804","DOI":"10.1016\/j.celrep.2021.108804","volume":"34","author":"DJ Harney","year":"2021","unstructured":"Harney, D. J. et al. Proteomics analysis of adipose depots after intermittent fasting reveals visceral fat preservation mechanisms. Cell Rep. 34, 108804 (2021).","journal-title":"Cell Rep."},{"key":"68423_CR83","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1021\/acs.jproteome.9b00090","volume":"18","author":"DJ Harney","year":"2019","unstructured":"Harney, D. J. et al. Proteomic analysis of human plasma during intermittent fasting. J. Proteome Res. 18, 2228\u20132240 (2019).","journal-title":"J. Proteome Res."},{"key":"68423_CR84","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","volume":"17","author":"V Demichev","year":"2020","unstructured":"Demichev, V., Messner, C. B., Vernardis, S. I., Lilley, K. S. & Ralser, M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat. Methods 17, 41\u201344 (2020).","journal-title":"Nat. Methods"},{"key":"68423_CR85","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, 638\u2013646 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68423_CR86","doi-asserted-by":"crossref","first-page":"21800","DOI":"10.1371\/journal.pone.0021800","volume":"6","author":"F Supek","year":"2011","unstructured":"Supek, F., Bosnjak, M., Skunca, N. & Smuc, T. REVIGO summarizes and visualizes long lists of gene ontology terms. PLoS ONE 6, 21800 (2011).","journal-title":"PLoS ONE"},{"key":"68423_CR87","doi-asserted-by":"crossref","first-page":"8894","DOI":"10.1002\/chem.201901640","volume":"25","author":"A Kiefer","year":"2019","unstructured":"Kiefer, A. et al. Synthesis of new cyclomarin derivatives and their biological evaluation towards Mycobacterium tuberculosis and Plasmodium falciparum. Chem. Eur. J. 25, 8894\u20138902 (2019).","journal-title":"Chem. Eur. J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68423-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68423-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68423-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T04:53:56Z","timestamp":1771390436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68423-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68423"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68423-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5493888\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1725"}}